Small Molecules
18 April 2017
NLS Pharma Announces Completion of Phase 2 Study for NLS-1, Its Lead ADHD Compound; New Investors, New Patents14 April 2017
Funding From Alzheimer’s Drug Discovery Foundation Advances M3 Biotechnology Toward Human Trials12 April 2017
Regen BioPharma, Inc. Sees Success in Its Pre-Clinical Small Molecule Optimization Program for NR2F612 April 2017
Kadmon Announces Publication of Clinical Data Showing KD025 Improved Clinical Scores in Psoriasis Patients12 April 2017
Saniona AB: Saniona’s partner, Medix, obtains approval to initiate Phase 3 study in obesity7 April 2017
Merck Receives Complete Response Letter from the U.S. FDA for TECOS Study with SitagliptinNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports